Association of homeostasis model assessment of insulin resistance, adiponectin, and low-grade inflammation with the course of the metabolic syndrome

Clinical Biochemistry

Volumn 48, Issue 7-8, 2015, Pages 503-507

  Ding, YuSong ^a   Li, ShuGang ^a   Ma, Ru Lin ^a   Guo, Heng ^a   Zhang, JingYu ^a   Zhang, Mei ^a   Liu, JiaMing ^a   Guo, ShuXia ^a  

^a SHIHEZI UNIVERSITY   (China)

Author keywords

Adiponectin; C reactive protein (CRP); Homeostasis model assessment of insulin of resistance (HOMA IR); IL 6; Metabolic syndrome (MetS)

Indexed keywords

ADIPONECTIN; ADIPOQ PROTEIN, HUMAN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; IL6 PROTEIN, HUMAN; INTERLEUKIN 6;

ADULT; BLOOD; FEMALE; HUMAN; IMMUNOLOGY; INFLAMMATION; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADIPONECTIN; ADULT; BIOMARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; INTERLEUKIN-6; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 84939940446     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2015.02.005     Document Type: Article

References (32)

1. Miranda P.J., DeFronzo R.A., Califf R.M., Guyton J.R. Metabolic syndrome: definition, pathophysiology, and mechanisms. Am Heart J 2005, 149:33-45.
2. Echahidi N., Pibarot P., Despres J.P., Daigle J.M., Mohty D., Voisine P., et al. Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery. J Am Coll Cardiol 2007, 50:843-851.
3. Luke J.N., Brown A., Daniel M., O'Dea K., Best J.D., Jenkins A.J., et al. The metabolic syndrome and cvd outcomes for a central Australian cohort. Diabetes Res Clin Pract 2013, 100:e70-e73.
4. Eckel R.H., Alberti K.G., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet 2010, 375:181-183.
5. Matsushita K., Tamakoshi K., Yatsuya H., Wada K., Otsuka R., Takefuji S., et al. Further inflammatory information on metabolic syndrome by adiponectin evaluation. Int J Cardiol 2008, 124:339-344.
6. Yoon J.H., Park J.K., Oh S.S., Lee K.H., Kim S.K., Cho I.J., et al. The ratio of serum leptin to adiponectin provides adjunctive information to the risk of metabolic syndrome beyond the homeostasis model assessment insulin resistance: the Korean genomic rural cohort study. Clin Chim Acta 2011, 412:2199-2205.
7. Cao Y., Yang T., Yu S., Sun G., Gu C., Yi D. Relationships of adiponectin with markers of systemic inflammation and insulin resistance in infants undergoing open cardiac surgery. Mediators Inflamm 2013, 2013:187940.
8. Saisho Y., Hirose H., Roberts R., Abe T., Kawabe H., Itoh H. C-reactive protein, high-molecular-weight adiponectin and development of metabolic syndrome in the Japanese general population: a longitudinal cohort study. PLoS One 2013, 8:e73430.
9. Yadav A., Kataria M.A., Saini V., Yadav A. Role of leptin and adiponectin in insulin resistance. Clin Chim Acta 2013, 417:80-84.
10. Kowalska I., Straczkowski M., Nikolajuk A., Adamska A., Karczewska-Kupczewska M., Otziomek E., et al. Insulin resistance, serum adiponectin, and proinflammatory markers in young subjects with the metabolic syndrome. Metabolism 2008, 57:1539-1544.
11. Matsubara T., Naruse K., Arakawa T., Nakao M., Yokoi K., Oguri M., et al. Impact of pitavastatin on high-sensitivity C-reactive protein and adiponectin in hypercholesterolemic patients with the metabolic syndrome: The premium study. J Cardiol 2012, 60:389-394.
12. Ahonen T.M., Saltevo J.T., Kautiainen H.J., Kumpusalo E.A., Vanhala M.J. The association of adiponectin and low-grade inflammation with the course of metabolic syndrome. Nutr Metab Cardiovasc Dis 2012, 22:285-291.
13. Choi K.M., Ryu O.H., Lee K.W., Kim H.Y., Seo J.A., Kim S.G., et al. Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome. Diabetes Res Clin Pract 2007, 75:235-240.
14. Penno G., Miccoli R., Pucci L., Del Prato S. The metabolic syndrome. Beyond the insulin resistance syndrome. Pharmacol Res 2006, 53:457-468.
15. Cinar N., Gurlek A. Association between novel adipocytokines adiponectin, vaspin, visfatin, and thyroid: an experimental and clinical update. Endocr Connect 2013, 2:R30-R38.
16. Rosen E.D., Spiegelman B.M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006, 444:847-853.
17. Saleem U., Mosley T.H., Kullo I.J. Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler Thromb Vasc Biol 2010, 30:1474-1478.
18. Nishida M., Moriyama T., Ishii K., Takashima S., Yoshizaki K., Sugita Y., et al. Effects of il-6, adiponectin, crp and metabolic syndrome on subclinical atherosclerosis. Clin Chim Acta 2007, 384:99-104.
19. Sun L., Pan A., Yu Z., Li H., Shi A., Yu D., et al. Snoring, inflammatory markers, adipokines and metabolic syndrome in apparently healthy Chinese. PLoS One 2011, 6:e27515.
20. Vaiopoulos A.G., Marinou K., Christodoulides C., Koutsilieris M. The role of adiponectin in human vascular physiology. Int J Cardiol 2012, 155:188-193.
21. Koh S.B., Yoon J., Kim J.Y., Yoo B.S., Lee S.H., Park J.K., et al. Relationships between serum adiponectin with metabolic syndrome and components of metabolic syndrome in non-diabetic Koreans: Arirang study. Yonsei Med J 2011, 52:234-241.
22. Koh S.B., Park J.K., Yoon J.H., Chang S.J., Oh S.S., Kim J.Y., et al. Preliminary report: a serious link between adiponectin levels and metabolic syndrome in a Korean nondiabetic population. Metab Clin Exp 2010, 59:333-337.
23. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
24. Alberti K.G., Zimmet P., Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005, 366:1059-1062.
25. Zhuo Q., Wang Z., Fu P., Piao J., Tian Y., Xu J., et al. Comparison of adiponectin, leptin and leptin to adiponectin ratio as diagnostic marker for metabolic syndrome in older adults of Chinese major cities. Diabetes Res Clin Pract 2009, 84:27-33.
26. Noto D., Niglio T., Cefalu A.B., Martino E., Fayer F., Mina M., et al. Obesity and the metabolic syndrome in a student cohort from southern Italy. Nutr Metab Cardiovasc Dis 2009, 19:620-625.
27. Antuna-Puente B., Feve B., Fellahi S., Bastard J.P. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab 2008, 34:2-11.
28. Kawamoto R., Tabara Y., Kohara K., Miki T., Kusunoki T., Takayama S., et al. Association between fasting plasma glucose and high-sensitivity c-reactive protein: gender differences in a Japanese community-dwelling population. Cardiovasc Diabetol 2011, 10:51.
29. Choi K.M., Yannakoulia M., Park M.S., Cho G.J., Kim J.H., Lee S.H., et al. Serum adipocyte fatty acid-binding protein, retinol-binding protein 4, and adiponectin concentrations in relation to the development of the metabolic syndrome in Korean boys: a 3-y prospective cohort study. Am J Clin Nutr 2011, 93:19-26.
30. Juonala M., Saarikoski L.A., Viikari J.S., Oikonen M., Lehtimaki T., Lyytikainen L.P., et al. A longitudinal analysis on associations of adiponectin levels with metabolic syndrome and carotid artery intima-media thickness. The cardiovascular risk in young Finns study. Atherosclerosis 2011, 217:234-239.
31. DeBoer M.D. Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: A need for screening tools to target interventions. Nutrition 2013, 29:379-386.
32. Guo S. Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms. J Endocrinol 2014, 220:T1-T23.